Table of Contents
Chromatography Research International
Volume 2013, Article ID 139459, 15 pages
http://dx.doi.org/10.1155/2013/139459
Review Article

Trends and Advances in Separation and Detection of SSRIs and SNRIs in Biological Matrices

Institute of Research and Development, Gujarat Forensic Sciences University, Sector 18/A, Gandhinagar, Gujarat 382007, India

Received 5 March 2013; Accepted 19 May 2013

Academic Editor: Toyohide Takeuchi

Copyright © 2013 Ruchita Das and Y. K. Agrawal. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Z. Potter and L. E. Hollister, “Antidepressant Agents,” in Lange: Basic and Clinical Pharmacology-Antidepressant Agent, B. G. Katzung, Ed., pp. 475–480, McGraw-Hill, New York, NY, USA, 2007. View at Google Scholar
  2. D. L. Musselman, D. L. Evans, and C. B. Nemeroff, “The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment,” Archives of General Psychiatry, vol. 55, no. 7, pp. 580–592, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Romero, A. Montero, B. Fernandez, and J. M. Vela, “Depressive disorders: introductory and basic aspects,” in Antidepressants, Antipsychotics, Anxiolytics—From Chemistry and Pharmacology to Clinical Application, H. Bushmann, J. Z. Diaz, J. Holenz, A. Parraga, A. Torrens, and J. M. Vela, Eds., pp. 3–35, Wiley-VCH, Weinheim, Germany, 2007. View at Google Scholar
  4. L. Iversen and R. D. Glennon, “Antidepressants,” in Burger: Medicinal Chemistry and Drug Discovery of Nervous System Agents, D. J. Abraham, Ed., pp. 484–517, John Wiley & Sons, New York, NY, USA, 2003. View at Google Scholar
  5. L. S. Goodman, G. J. Hardman, L. E. Limbird, and A. G. Gilman, Goodman & Gilman’s the Pharmacological basis of therepeutics, McGraw-Hill, New York, NY, USA, 2001.
  6. D. Murdoch and D. McTavish, “Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder,” Drugs, vol. 44, no. 4, pp. 604–624, 1992. View at Google Scholar · View at Scopus
  7. M. Bauer, B. U. Monz, A. L. Montejo et al., “Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) study,” European Psychiatry, vol. 23, no. 1, pp. 66–73, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. H. P. Rang, M. M. Dale, J. M. Ritter, and J. M. Flower, Rang & Dale’s Pharmacology, Elsevier, Churchill Levingstone, New York, NY, USA, 2007.
  9. I. M. Anderson, “Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability,” Journal of Affective Disorders, vol. 58, no. 1, pp. 19–36, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Markowitz and A. Cuellar, “Antidepressants and youth: healing or harmful?” Social Science and Medicine, vol. 64, no. 10, pp. 2138–2151, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Y. Katz, A. L. Kozyrskyj, H. J. Prior, M. W. Enns, B. J. Cox, and J. Sareen, “Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults,” Canadian Medical Association Journal, vol. 178, no. 8, pp. 1005–1011, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. J. N. Jureidini, C. J. Doecke, P. R. Mansfield, M. M. Haby, D. B. Menkes, and A. L. Tonkin, “Efficacy and safety of antidepressants for children and adolescents,” British Medical Journal, vol. 328, no. 7444, pp. 879–883, 2004. View at Google Scholar · View at Scopus
  13. S. M. R. Wille, E. A. de Letter, M. H. A. Piette, L. K. van Overschelde, C. H. van Peteghem, and W. E. Lambert, “Determination of antidepressants in human postmortem blood, brain tissue, and hair using gas chromatography-mass spectrometry,” International Journal of Legal Medicine, vol. 123, no. 6, pp. 451–458, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. W. D. Hall, A. Mant, P. B. Mitchell, V. A. Rendle, I. B. Hickie, and P. McManus, “Association between antidepressant prescribing and suicide in Australia, 1991–2000: trend analysis,” British Medical Journal, vol. 326, no. 7397, pp. 1008–1011, 2003. View at Google Scholar · View at Scopus
  15. G. Isacsson, “Suicide prevention—a medical breakthrough?” Acta Psychiatrica Scandinavica, vol. 102, no. 2, pp. 113–117, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Adamowicz and M. Kała, “Simultaneous screening for and determination of 128 date-rape drugs in urine by gas chromatography-electron ionization-mass spectrometry,” Forensic Science International, vol. 198, no. 1–3, pp. 39–45, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. R. F. Suckow, M. F. Z. Ming Fen Zhang, and T. B. Cooper, “Sensitive and selective liquid-chromatographic assay of fluoxetine and norfluoxetine in plasma with fluorescence detection after precolumn derivatization,” Clinical Chemistry, vol. 38, no. 9, pp. 1756–1761, 1992. View at Google Scholar · View at Scopus
  18. A. Esrafili, Y. Yamini, and S. Shariati, “Hollow fiber-based liquid phase microextraction combined with high-performance liquid chromatography for extraction and determination of some antidepressant drugs in biological fluids,” Analytica Chimica Acta, vol. 604, no. 2, pp. 127–133, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. B. V. Reddy, K. V. N. S. Reddy, J. Sreeramulu, and G. V. Kanumula, “Simultaneous determination of olanzapine and fluoxetine by HPLC,” Chromatographia, vol. 66, no. 1-2, pp. 111–114, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Coulter, M. Taruc, J. Tuyay, and C. Moore, “Antidepressant drugs in oral fluid using liquid chromatography-tandem mass spectrometry,” Journal of Analytical Toxicology, vol. 34, no. 2, pp. 64–72, 2010. View at Google Scholar · View at Scopus
  21. B. N. Patel, N. Sharma, M. Sanyal, and P. S. Shrivastav, “Analysis of second-generation antidepressant drug, sertraline and its active metabolite, N-desmethyl sertraline in human plasma by a sensitive and selective liquid chromatography-tandem mass spectrometry method,” Journal of Chromatography B, vol. 877, no. 3, pp. 221–229, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Mandrioli, M. A. Saracino, S. Ferrari, D. Berardi, E. Kenndler, and M. A. Raggi, “HPLC analysis of the second-generation antidepressant sertraline and its main metabolite N-desmethylsertraline in human plasma,” Journal of Chromatography B, vol. 836, no. 1-2, pp. 116–119, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. K. E. Goeringer, I. M. McIntyre, and O. H. Drummer, “LC-MS analysis of serotonergic drugs,” Journal of Analytical Toxicology, vol. 27, no. 1, pp. 30–35, 2003. View at Google Scholar · View at Scopus
  24. M. Kollroser and C. Schober, “An on-line solid phase extraction—liquid chromatography—tandem mass spectrometry method for the analysis of citalopram, fluvoxamine, and paroxetine in human plasma,” Chromatographia, vol. 57, no. 3-4, pp. 133–138, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Djordjevic, I. Kovacevic, B. Miljkovic, J. Vuksanovic, and M. Pokrajac, “Liquid chromatographic-mass spectrometric method for the determination of fluoxetine and norfluoxetine in human plasma: application to clinical study,” Farmaco, vol. 60, no. 4, pp. 345–349, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Fernandes, P. Jiayu, P. Sandra, and F. M. Lanças, “Stir bar sorptive extraction-LC-MS for the analysis of fluoxetine in plasma,” Chromatographia, vol. 64, no. 9-10, pp. 517–521, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. X. Chen, X. Duan, X. Dai, and D. Zhong, “Development and validation of a liquid chromatographic/tandem mass spectrometric method for the determination of sertraline in human plasma,” Rapid Communications in Mass Spectrometry, vol. 20, no. 16, pp. 2483–2489, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. A. de Castro, M. D. M. R. Fernandez, M. Laloup et al., “High-throughput on-line solid-phase extraction-liquid chromatography-tandem mass spectrometry method for the simultaneous analysis of 14 antidepressants and their metabolites in plasma,” Journal of Chromatography A, vol. 1160, no. 1-2, pp. 3–12, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. A. J. Santos-Neto, J. Bergquist, F. M. Lanças, and P. J. R. Sjöberg, “Simultaneous analysis of five antidepressant drugs using direct injection of biofluids in a capillary restricted-access media-liquid chromatography-tandem mass spectrometry system,” Journal of Chromatography A, vol. 1189, no. 1-2, pp. 514–522, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. M.-M. Zheng, S.-T. Wang, W.-K. Hu, and Y.-Q. Feng, “In-tube solid-phase microextraction based on hybrid silica monolith coupled to liquid chromatography-mass spectrometry for automated analysis of ten antidepressants in human urine and plasma,” Journal of Chromatography A, vol. 1217, no. 48, pp. 7493–7501, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Hattori, K. Ito, M. Iwai et al., “Rapid analysis of sertraline, fluvoxamine, and paroxetine in serum specimens by LC-MS-MS using a new polymer column,” Forensic Toxicology, vol. 25, no. 2, pp. 100–103, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. M. A. Raggi, V. Pucci, R. Mandrioli, C. Sabbioni, and S. Fanali, “Determination of recent antidepressant citalopram in human plasma by liquid chromatography—fluorescence detection,” Chromatographia, vol. 57, no. 5-6, pp. 273–278, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Frison, D. Favretto, S. Vogliardi, C. Terranova, and S. D. Ferrara, “Quantification of citalopram or escitalopram and their demethylated metabolites in neonatal hair samples by liquid chromatography-tandem mass spectrometry,” Therapeutic Drug Monitoring, vol. 30, no. 4, pp. 467–473, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Zhu, J. Luo, G. Zheng, and J. Shentu, “Sensitive and specific liquid chromatography-tandem mass spectrometry method for assay of fluoxetine and its metabolite norfluoxetine in human plasma and application of method to pharmacokinetic analysis,” Journal of Analytical Chemistry, vol. 64, no. 9, pp. 941–950, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Kirchherr and W. N. Kühn-Velten, “Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach,” Journal of Chromatography B, vol. 843, no. 1, pp. 100–113, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. M. K. K. Nielsen, S. S. Johansen, P. W. Dalsgaard, and K. Linnet, “Simultaneous screening and quantification of 52 common pharmaceuticals and drugs of abuse in hair using UPLC-TOF-MS,” Forensic Science International, vol. 196, no. 1–3, pp. 85–92, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. D. Favretto, S. Vogliardi, G. Stocchero, A. Nalesso, M. Tucci, and S. D. Ferrara, “High performance liquid chromatography-high resolution mass spectrometry and micropulverized extraction for the quantification of amphetamines, cocaine, opioids, benzodiazepines, antidepressants and hallucinogens in 2.5 mg hair samples,” Journal of Chromatography A, vol. 1218, no. 38, pp. 6583–6595, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. P. P. Rop, A. Viala, A. Durand, and T. Conquy, “Determination of citalopram, amitryptyline and clomipramine in plasma by reversed-phase high-performance liquid chromatography,” Journal of Chromatography, vol. 338, no. 1, pp. 171–178, 1985. View at Google Scholar · View at Scopus
  39. J. Macek, P. Ptáček, and J. Klíma, “Rapid determination of citalopram in human plasma by high-performance liquid chromatography,” Journal of Chromatography B, vol. 755, no. 1-2, pp. 279–285, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. E. M. Koves, “Use of high-performance liquid chromatography-diode array detection in forensic toxicology,” Journal of Chromatography A, vol. 692, no. 1-2, pp. 103–119, 1995. View at Publisher · View at Google Scholar · View at Scopus
  41. I. M. McIntyre, C. V. King, S. Skafidis, and O. H. Drummer, “Dual ultaviolet wavelength high-performance liquid chromatographic method for the forensic or clinical analysis of seventeen antidepressants and some selected metabolites,” Journal of Chromatography, vol. 621, no. 2, pp. 215–223, 1993. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Frahnert, M. L. Rao, and K. Grasmäder, “Analysis of eighteen antidepressants, four atypical antipsychotics and active metabolites in serum by liquid chromatography: a simple tool for therapeutic drug monitoring,” Journal of Chromatography B, vol. 794, no. 1, pp. 35–47, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. A. L. Hostetter, Z. N. Stowe, M. Cox, and J. C. Ritchie, “A novel system for the determination of antidepressant concentrations in human breast milk,” Therapeutic Drug Monitoring, vol. 26, no. 1, pp. 47–52, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. A. R. Chaves, G. Chiericato Júnior, and M. E. C. Queiroz, “Solid-phase microextraction using poly(pyrrole) film and liquid chromatography with UV detection for analysis of antidepressants in plasma samples,” Journal of Chromatography B, vol. 877, no. 7, pp. 587–593, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Greiner, C. Hiemke, W. Bader, and E. Haen, “Determination of citalopram and escitalopram together with their active main metabolites desmethyl(es-)citalopram in human serum by column-switching high performance liquid chromatography (HPLC) and spectrophotometric detection,” Journal of Chromatography B, vol. 848, no. 2, pp. 391–394, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Oztunc, A. Onal, and S. Erturk, “7,7,8,8-Tetracyanoquinodimethane as a new derivatization reagent for high-performance liquid chromatography and thin-layer chromatography: rapid screening of plasma for some antidepressants,” Journal of Chromatography B, vol. 774, no. 2, pp. 149–155, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. K. F. Overo, “Preliminary studies of the kinetics of citalopram in man,” European Journal of Clinical Pharmacology, vol. 14, no. 1, pp. 69–73, 1978. View at Google Scholar · View at Scopus
  48. E. Matsui, M. Hoshino, A. Matsui, and A. Okahira, “Simultaneous determination of citalopram and its metabolites by high-performance liquid chromatography with column switching and fluorescence detection by direct plasma injection,” Journal of Chromatography B, vol. 668, no. 2, pp. 299–307, 1995. View at Publisher · View at Google Scholar · View at Scopus
  49. N. Unceta, A. Ugarte, A. Sánchez, A. Gómez-Caballero, M. A. Goicolea, and R. J. Barrio, “Development of a stir bar sorptive extraction based HPLC-FLD method for the quantification of serotonin reuptake inhibitors in plasma, urine and brain tissue samples,” Journal of Pharmaceutical and Biomedical Analysis, vol. 51, no. 1, pp. 178–185, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. E. Lacassie, J.-M. Gaulier, P. Marquet, J.-F. Rabatel, and G. Lachâtre, “Methods for the determination of seven selective serotonin reuptake inhibitors and three active metabolites in human serum using high-performance liquid chromatography and gas chromatography,” Journal of Chromatography B, vol. 742, no. 2, pp. 229–238, 2000. View at Publisher · View at Google Scholar · View at Scopus
  51. Y. Higashi, H. Matsumura, and Y. Fujii, “Determination of fluvoxamine in rat plasma by HPLC with pre-column derivatization and fluorescence detection using 4-fluoro-7-nitro-2,1,3-benzoxadiazole,” Biomedical Chromatography, vol. 19, no. 10, pp. 771–776, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. G. Bahrami, B. Mohammadi, A. Farshchi, and G. Ghiasi, “Quantitative analysis of sertraline in human serum by LC with fluorescence detection after pre-column derivatization with 4-chloro-7-nitrobenzofurazan,” Chromatographia, vol. 70, no. 1-2, pp. 323–327, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. G. J. de Jong and J. Zeeman, “The potential of pre-columns to improve detection properties in high-performance liquid chromatography,” Chromatographia, vol. 15, no. 7, pp. 453–458, 1982. View at Google Scholar · View at Scopus
  54. R. H. Pullen and A. A. Fatmi, “Determination of fluvoxamine in human plasma by high-performance liquid chromatography with fluorescence detection,” Journal of Chromatography, vol. 574, no. 1, pp. 101–107, 1992. View at Publisher · View at Google Scholar · View at Scopus
  55. J. J. B. Nevado, M. J. V. Llerena, C. G. Cabanillas, V. R. Robledo, and S. Buitrago, “Sensitive capillary GC-MS-SIM determination of selective serotonin reuptake inhibitors: reliability evaluation by validation and robustness study,” Journal of Separation Science, vol. 29, no. 1, pp. 103–113, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. C. B. Eap, “Simultaneous determination of human plasma levels of citalopram, paroxetine, sertraline, and their metabolites by gas chromatography-mass spectrometry,” Journal of Chromatographic Science, vol. 36, no. 7, pp. 365–371, 1998. View at Google Scholar · View at Scopus
  57. C. Salgado-Petinal, J. P. Lamas, C. Garcia-Jares, M. Llompart, and R. Cela, “Rapid screening of selective serotonin re-uptake inhibitors in urine samples using solid-phase microextraction gas chromatography-mass spectrometry,” Analytical and Bioanalytical Chemistry, vol. 382, no. 6, pp. 1351–1359, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. T. Gunnar, S. Mykkänen, K. Ariniemi, and P. Lillsunde, “Validated semiquantitative/quantitative screening of 51 drugs in whole blood as silylated derivatives by gas chromatography-selected ion monitoring mass spectrometry and gas chromatography electron capture detection,” Journal of Chromatography B, vol. 806, no. 2, pp. 205–219, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. U. Staerk and W. R. Külpmann, “High-temperature solid-phase microextraction procedure for the detection of drugs by gas chromatography-mass spectrometry,” Journal of Chromatography B, vol. 745, no. 2, pp. 399–411, 2000. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Pujadas, S. Pichini, E. Civit, E. Santamariña, K. Perez, and R. de la Torre, “A simple and reliable procedure for the determination of psychoactive drugs in oral fluid by gas chromatography-mass spectrometry,” Journal of Pharmaceutical and Biomedical Analysis, vol. 44, no. 2, pp. 594–601, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. K. Fu, R. J. Konrad, R. W. Hardy, R. M. Brissie, and C. A. Robinson, “An unusual multiple drug intoxication case involving citalopram,” Journal of Analytical Toxicology, vol. 24, no. 7, pp. 648–650, 2000. View at Google Scholar · View at Scopus
  62. S. M. Song, P. Marriott, A. Kotsos, O. H. Drummer, and P. Wynne, “Comprehensive two-dimensional gas chromatography with time-of-flight mass spectrometry (GC x GC-TOFMS) for drug screening and confirmation,” Forensic Science International, vol. 143, no. 2-3, pp. 87–101, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. E. Lacassie, J.-M. Gaulier, P. Marquet, J.-F. Rabatel, and G. Lachâtre, “Methods for the determination of seven selective serotonin reuptake inhibitors and three active metabolites in human serum using high-performance liquid chromatography and gas chromatography,” Journal of Chromatography B, vol. 742, no. 2, pp. 229–238, 2000. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Ulrich, “Direct stereoselective assay of fluoxetine and norfluoxetine enantiomers in human plasma or serum by two-dimensional gas-liquid chromatography with nitrogen-phosphorus selective detection,” Journal of Chromatography B, vol. 783, no. 2, pp. 481–490, 2003. View at Publisher · View at Google Scholar · View at Scopus
  65. M. A. Martínez, C. Sánchez de la Torre, and E. Almarza, “Simultaneous determination of viloxazine, venlafaxine, imipramine, desipramine, sertraline, and amoxapine in whole blood: comparison of two extraction/cleanup procedures for capillary gas chromatography with nitrogen-phosphorus detection,” Journal of Analytical Toxicology, vol. 26, no. 5, pp. 296–302, 2002. View at Google Scholar · View at Scopus
  66. C. Sánchez de la Torre, M. A. Martínez, and E. Almarza, “Determination of several psychiatric drugs in whole blood using capillary gas-liquid chromatography with nitrogen phosphorus detection: comparison of two solid phase extraction procedures,” Forensic Science International, vol. 155, no. 2-3, pp. 193–204, 2005. View at Publisher · View at Google Scholar · View at Scopus
  67. D. Schaller, E. F. Hilder, and P. R. Haddad, “Separation of antidepressants by capillary electrophoresis with in-line solid-phase extraction using a novel monolithic adsorbent,” Analytica Chimica Acta, vol. 556, no. 1, pp. 104–111, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. S. Andersen, T. G. Halvorsen, S. Pedersen-Bjergaard, K. E. Rasmussen, L. Tanum, and H. Refsum, “Stereospecific determination of citalopram and desmethylcitalopram by capillary electrophoresis and liquid-phase microextraction,” Journal of Pharmaceutical and Biomedical Analysis, vol. 33, no. 2, pp. 263–273, 2003. View at Publisher · View at Google Scholar · View at Scopus
  69. T. G. Halvorsen, S. Pedersen-Bjergaard, and K. E. Rasmussen, “Liquid-phase microextraction and capillary electrophoresis of citalopram, an antidepressant drug,” Journal of Chromatography A, vol. 909, no. 1, pp. 87–93, 2001. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Cherkaoui, S. Rudaz, and J. L. Veuthey, “Nonaqueous capillary electrophoresis-mass spectrometry for separation of venlafaxine and its phase I metabolites,” Electrophoresis, vol. 22, pp. 491–496, 2001. View at Google Scholar
  71. L. Labat, M. Deveaux, P. Dallet, and J. P. Dubost, “Separation of new antidepressants and their metabolites by micellar electrokinetic capillary chromatography,” Journal of Chromatography B, vol. 773, no. 1, pp. 17–23, 2002. View at Publisher · View at Google Scholar · View at Scopus
  72. J. Rodríguez Flores, A. M. C. Salcedo, M. J. V. Llerena, and L. M. Fernández, “Micellar electrokinetic chromatographic method for the determination of letrozole, citalopram and their metabolites in human urine,” Journal of Chromatography A, vol. 1185, no. 2, pp. 281–290, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. T. Buzinkaiova and J. Polonsky, “Determination of four selective serotonin reuptake inhibitors by capillary isotachophoresis,” Electrophoresis, vol. 21, pp. 2839–2841, 2000. View at Google Scholar
  74. H.-L. Su and Y.-Z. Hsieh, “Using cation-selective exhaustive injection and sweeping micellar electrokinetic chromatography to determine selective serotonin reuptake inhibitors,” Journal of Chromatography A, vol. 1209, no. 1-2, pp. 253–259, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. W. Liu, F. Wang, and H.-D. Li, “Simultaneous stereoselective analysis of venlafaxine and O-desmethylvenlafaxine enantiomers in human plasma by HPLC-ESI/MS using a vancomycin chiral column,” Journal of Chromatography B, vol. 850, no. 1-2, pp. 183–189, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. D. S. Jain, M. Sanyal, G. Subbaiah, U. C. Pande, and P. Shrivastav, “Rapid and sensitive method for the determination of sertraline in human plasma using liquid chromatography-tandem mass spectrometry (LC-MS/MS),” Journal of Chromatography B, vol. 829, no. 1-2, pp. 69–74, 2005. View at Publisher · View at Google Scholar · View at Scopus
  77. A. de Castro, M. Concheiro, O. Quintela, A. Cruz, and M. López-Rivadulla, “LC-MS/MS method for the determination of nine antidepressants and some of their main metabolites in oral fluid and plasma. Study of correlation between venlafaxine concentrations in both matrices,” Journal of Pharmaceutical and Biomedical Analysis, vol. 48, no. 1, pp. 183–193, 2008. View at Publisher · View at Google Scholar · View at Scopus
  78. R. Green, R. Houghton, J. Scarth, and C. Gregory, “Determination of fluoxetine and its major active metabolite norfluoxetine in human plasma by liquid chromatography-tandem mass spectrometry,” Chromatographia, vol. 55, pp. S133–S136, 2002. View at Google Scholar · View at Scopus
  79. S. Souverain, M. Mottaz, S. Cherkaoui, and J.-L. Veuthey, “Rapid analysis of fluoxetine and its metabolite in plasma by LC-MS with column-switching approach,” Analytical and Bioanalytical Chemistry, vol. 377, no. 5, pp. 880–885, 2003. View at Publisher · View at Google Scholar · View at Scopus
  80. J. Bhatt, A. Jangid, G. Venkatesh, G. Subbaiah, and S. Singh, “Liquid chromatography-tandem mass spectrometry (LC-MS-MS) method for simultaneous determination of venlafaxine and its active metabolite O-desmethyl venlafaxine in human plasma,” Journal of Chromatography B, vol. 829, no. 1-2, pp. 75–81, 2005. View at Publisher · View at Google Scholar · View at Scopus
  81. C. Pistos, I. Panderi, and J. Atta-Politou, “Liquid chromatography-positive ion electrospray mass spectrometry method for the quantification of citalopram in human plasma,” Journal of Chromatography B, vol. 810, no. 2, pp. 235–244, 2004. View at Publisher · View at Google Scholar · View at Scopus
  82. T. Jiang, Z. X. Rong, L. Peng et al., “Simultaneous determination of citalopram and its metabolite in human plasma by LC-MS/MS applied to pharmacokinetic study,” Journal of Chromatography B, vol. 878, no. 5-6, pp. 615–619, 2010. View at Publisher · View at Google Scholar · View at Scopus
  83. T. Shinozuka, M. Terada, and E. Tanaka, “Solid-phase extraction and analysis of 20 antidepressant drugs in human plasma by LC/MS with SSI method,” Forensic Science International, vol. 162, no. 1–3, pp. 108–112, 2006. View at Publisher · View at Google Scholar · View at Scopus
  84. F. C. W. Sutherland, D. Badenhorst, A. D. de Jager et al., “Sensitive liquid chromatographic-tandem mass spectrometric method for the determination of fluoxetine and its primary active metabolite norfluoxetine in human plasma,” Journal of Chromatography A, vol. 914, no. 1-2, pp. 45–51, 2001. View at Publisher · View at Google Scholar · View at Scopus
  85. H. Juan, Z. Zhiling, and L. Huande, “Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI),” Journal of Chromatography B, vol. 820, no. 1, pp. 33–39, 2005. View at Publisher · View at Google Scholar · View at Scopus
  86. N. Castaing, K. Titier, M. Receveur-Daurel et al., “Quantification of eight new antidepressants and five of their active metabolites in whole blood by high-performance liquid chromatography-tandem mass spectrometry,” Journal of Analytical Toxicology, vol. 31, no. 6, pp. 334–341, 2007. View at Google Scholar · View at Scopus
  87. W. R. Malfará, C. Bertucci, M. E. Costa Queiroz et al., “Reliable HPLC method for therapeutic drug monitoring of frequently prescribed tricyclic and nontricyclic antidepressants,” Journal of Pharmaceutical and Biomedical Analysis, vol. 44, no. 4, pp. 955–962, 2007. View at Publisher · View at Google Scholar · View at Scopus
  88. V. F. Samanidou and P. V. Kourti, “Rapid HPLC method for the simultaneous monitoring of duloxetine, venlaflaxine, fluoxetine and paroxetine in biofluids,” Bioanalysis, vol. 1, no. 5, pp. 905–917, 2009. View at Google Scholar · View at Scopus
  89. P. Molander, A. Thomassen, L. Kristoffersen, T. Greibrokk, and E. Lundanes, “Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma by temperature-programmed packed capillary liquid chromatography with on-column focusing of large injection volumes,” Journal of Chromatography B, vol. 766, no. 1, pp. 77–87, 2002. View at Publisher · View at Google Scholar · View at Scopus
  90. K. Titier, N. Castaing, E. Scotto-Gomez, F. Pehourcq, N. Moore, and M. Molimard, “High-performance liquid chromatographic method with diode array detection for identification and quantification of the eight new antidepressants and five of their active metabolites in plasma after overdose,” Therapeutic Drug Monitoring, vol. 25, no. 5, pp. 581–587, 2003. View at Publisher · View at Google Scholar · View at Scopus
  91. Z. Zheng, M. Jamour, and U. Klotz, “Stereoselective HPLC-assay for citalopram and its metabolites,” Therapeutic Drug Monitoring, vol. 22, no. 2, pp. 219–224, 2000. View at Publisher · View at Google Scholar · View at Scopus
  92. L. Kristoffersen, A. Bugge, E. Lundanes, and L. Slørdal, “Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma and whole blood by high-performance liquid chromatography with ultraviolet and fluorescence detection,” Journal of Chromatography B, vol. 734, no. 2, pp. 229–246, 1999. View at Publisher · View at Google Scholar · View at Scopus
  93. R. Waschgler, M. R. Hubmann, A. Conca, W. Moll, and P. König, “Simultaneous quantification of citalopram, clozapine, fluoxetine, norfluoxetine, maprotiline, desmethylmaprotiline and trazodone in human serum by HPLC analysis,” International Journal of Clinical Pharmacology and Therapeutics, vol. 40, no. 12, pp. 554–559, 2002. View at Google Scholar · View at Scopus
  94. B. Carlsson and B. Norlander, “Solid-phase extraction with end-capped C2 columns for the routine measurement of racemic citalopram and metabolites in plasma by high- performance liquid chromatography,” Journal of Chromatography B, vol. 702, no. 1-2, pp. 234–239, 1997. View at Publisher · View at Google Scholar · View at Scopus
  95. C. Duverneuil, G. L. de la Grandmaison, P. de Mazancourt, and J.-C. Alvarez, “A high-performance liquid chromatography method with photodiode-array UV detection for therapeutic drug monitoring of the nontricyclic antidepressant drugs,” Therapeutic Drug Monitoring, vol. 25, no. 5, pp. 565–573, 2003. View at Publisher · View at Google Scholar · View at Scopus
  96. N. Unceta, A. Gómez-Caballero, A. Sánchez et al., “Simultaneous determination of citalopram, fluoxetine and their main metabolites in human urine samples by solid-phase microextraction coupled with high-performance liquid chromatography,” Journal of Pharmaceutical and Biomedical Analysis, vol. 46, no. 4, pp. 763–770, 2008. View at Publisher · View at Google Scholar · View at Scopus
  97. S. M. R. Wille, P. van Hee, H. M. Neels, C. H. van Peteghem, and W. E. Lambert, “Comparison of electron and chemical ionization modes by validation of a quantitative gas chromatographic-mass spectrometric assay of new generation antidepressants and their active metabolites in plasma,” Journal of Chromatography A, vol. 1176, no. 1-2, pp. 236–245, 2007. View at Publisher · View at Google Scholar · View at Scopus
  98. P. Reymond, M. Amey, A. Souche et al., “Determination of plasma levels of citalopram and its demethylated and deaminated metabolites by gas chromatography and gas chromatography-mass spectrometry,” Journal of Chromatography, vol. 616, no. 2, pp. 221–228, 1993. View at Publisher · View at Google Scholar · View at Scopus
  99. M. A. Martínez, C. Sánchez de la Torre, and E. Almarza, “A comparative solid-Phase extraction study for the simultaneous determination of fluvoxamine, mianserin, doxepin, citalopram, paroxetine, and etoperidone in whole blood by capillary gas-liquid chromatography with nitrogen-phosphorus detection,” Journal of Analytical Toxicology, vol. 28, no. 3, pp. 174–180, 2004. View at Google Scholar · View at Scopus
  100. J. J. Berzas, C. Guiberteau, M. J. Villaseñor, and V. Rodríguez, “Development of a capillary gas chromatographic procedure,” Analytica Chimica Acta, vol. 519, no. 2, pp. 219–230, 2004. View at Publisher · View at Google Scholar · View at Scopus
  101. B. J. G. Silva, F. M. Lanças, and M. E. C. Queiroz, “In-tube solid-phase microextraction coupled to liquid chromatography (in-tube SPME/LC) analysis of nontricyclic antidepressants in human plasma,” Journal of Chromatography B, vol. 862, no. 1-2, pp. 181–188, 2008. View at Publisher · View at Google Scholar · View at Scopus